Dhalla Kazim, Cousens Simon, Bowman Richard, Wood Mark, Murdoch Ian
Department of Ophthalmology, Comprehensive Community Based Rehabilitation Hospital in Tanzania (CCBRT), Dar Es Salaam, Tanzania.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine (LSHTM), London, United Kingdom.
PLoS One. 2016 Sep 8;11(9):e0161674. doi: 10.1371/journal.pone.0161674. eCollection 2016.
In an African setting surgery is generally accepted as the treatment of first choice for glaucoma. A problem with trabeculectomy surgery for the glaucomas is the frequent co-existence and exacerbation of cataract. We report a randomized controlled trial to compare the use of beta radiation with 5FU in combined cataract and glaucoma surgery.
Consenting adults aged >40 years with glaucoma, an IOP>21mmHG and cataract were enrolled and randomised to receive either 1000cG β radiation application or sub-conjunctival 5fluorouracil (5FU) at the time of combined trabeculectomy and phaco-emulsification with lens implant surgery.
385 individuals were eligible for inclusion of whom 301 consented to inclusion in the study (one eye per patient). 150 were randomised to the 5FU arm and 151 received β radiation. In the 12 months following surgery there were 40 failures (IOP>21mmHg) in the 5FU arm and 34 failures in the beta arm. The hazard ratio for the beta radiation arm compared to the 5FU arm, adjusted for IOP at baseline, was 0.83 (95% c.i. 0.54 to 1.28; P = 0.40). The improvement from mean presenting visual acuities of 0.91 and 0.86 logMAR to 0.62 and 0.54 in the 5FU and beta arms respectively was comparable between groups (P = 0.4 adjusting for baseline VA). Incidence of complications did not differ between the two groups.
This study highlights several important issues in the quest for a therapeutic strategy for the glaucomas in an African context. Firstly, there is no evidence of an important difference between the use of 5FU and beta radiation as an anti-metabolite in phacotrabeculectomy. Secondly phacotrabeculectomy is a successful operation that improves visual acuity as well as controlling IOP in a majority of patients. Although the success of trabeculectomy in lowering IOP is reduced when combined with phacoemulsification compared with trabeculectomy alone, this finding has to be set against the possible need for subsequent cataract surgery following trabeculectomy alone, which represents a second trip and expense for the patient and results in 10-61% failure of the trabeculectomy at one year post-cataract surgery.
ISRCTN Registry ISRCTN36436933.
在非洲地区,手术普遍被认为是青光眼的首选治疗方法。青光眼小梁切除术的一个问题是白内障经常并存且病情加重。我们报告一项随机对照试验,比较β射线与5-氟尿嘧啶(5FU)在白内障合并青光眼手术中的应用。
年龄大于40岁、患有青光眼、眼压>21mmHg且有白内障并同意参与的成年人被纳入研究,并随机分为两组,一组在小梁切除术联合超声乳化晶状体植入手术时接受1000cGβ射线照射,另一组接受结膜下注射5-氟尿嘧啶(5FU)。
385人符合纳入标准,其中301人同意参与研究(每位患者一只眼)。150人被随机分配到5FU组,151人接受β射线照射。术后12个月,5FU组有40例治疗失败(眼压>21mmHg),β射线组有34例。在对基线眼压进行调整后,β射线组与5FU组相比的风险比为0.83(95%置信区间为0.54至1.28;P = 0.40)。两组患者的平均初始视力从5FU组的0.91 logMAR和β射线组的0.86 logMAR分别改善至0.62和0.54,两组之间具有可比性(根据基线视力调整后P = 0.4)。两组并发症的发生率没有差异。
本研究突出了在非洲背景下寻求青光眼治疗策略过程中的几个重要问题。首先,没有证据表明在超声乳化小梁切除术中使用5FU和β射线作为抗代谢物存在重要差异。其次,超声乳化小梁切除术是一种成功的手术,可提高大多数患者的视力并控制眼压。尽管与单纯小梁切除术相比,小梁切除术联合超声乳化术降低眼压的成功率有所降低,但这一发现必须与单纯小梁切除术后可能需要进行后续白内障手术的情况相权衡,这对患者来说意味着第二次就医和费用,并且在白内障手术后一年小梁切除术的失败率为10 - 61%。
国际标准随机对照试验编号ISRCTN36436933 。